US Stock MarketDetailed Quotes

SYRE Spyre Therapeutics

Watchlist
  • 29.940
  • -1.530-4.86%
Close Jul 29 16:00 ET
  • 29.940
  • 0.0000.00%
Post 16:02 ET
1.52BMarket Cap-659P/E (TTM)

About Spyre Therapeutics Company

Spyre Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in the development of next-generation human enzyme therapeutics as disruptive solutions for rare and other high-burden diseases. Its product, Pegzilarginase, is in a Phase 3 pivotal trial for the treatment of Arginase 1 Deficiency. The company was founded by George Georgiou and David G. Lowe on December 16, 2013 and is headquartered in Waltham, MA.

Company Profile

SymbolSYRE
Company NameSpyre Therapeutics
Listing DateApr 7, 2016
Founded2013
CEODr. Cameron Turtle, D.Phil.
MarketNASDAQ
Employees30
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
AddressBuilding 17,221 Crescent Street,Suite 102B
CityWaltham
ProvinceMassachusetts
CountryUnited States of America
Zip Code02453
Phone1-617-651-5940
Websitehttp://www.spyre.com

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Cameron Turtle, D.Phil.
  • Director, President and Chief Executive Officer
  • 15.92M
  • Dr. Scott L. Burrows, M.D.
  • Chief Financial Officer and Principal Accounting Officer
  • 7.55M
  • Heidy King-Jones
  • Chief Legal Officer and Corporate Secretary
  • 6.59M
  • Jeffrey W. Albers, J.D.
  • Chairman of the Board
  • 433.57K
  • Dr. Sandra Milligan, J.D.
  • Director
  • --
  • Dr. Michael Henderson, M.D.
  • Independent Director
  • --
  • Tomas Kiselak
  • Independent Director
  • 658.43K
  • Peter Harwin
  • Independent Director
  • 661.28K
  • Laurie D. Stelzer, M.B.A.
  • Independent Director
  • 434.38K
  • Mark C. McKenna
  • Independent Director
  • --

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg